Finance

Lists
LH:NYSE
Labcorp Holdings Inc
US$ ३१२.१५
-०.६५%
(-२.०५) 1D
US$ ३११.८४
-०.१०% (-०.३१)
After hours
Closed: अक्टोबर ९, १६:००:०४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
US$ ३१३.३९
High
US$ ३१८.१८
Low
US$ ३११.६२
Mkt. cap
२५.३२ अरब
Avg. vol.
७.७७ लाख
Volume
६.०८ लाख
Dividend
०.९२%
Quarterly dividend
US$ ०.७२
Ex-dividend date
२०२६ मे २९
P/E ratio
२५.८१
52-wk high
US$ ३४१.८०
52-wk low
US$ २४४.५२
EPS
US$ १२.०९
Beta
०.८८
Shares outstanding
८.११ करोड
No. of employees
७१ हजार
Open
US$ ३१३.३९
High
US$ ३१८.१८
Low
US$ ३११.६२
Mkt. cap
२५.३२ अरब
Avg. vol.
७.७७ लाख
Volume
६.०८ लाख
Dividend
०.९२%
Quarterly dividend
US$ ०.७२
Ex-dividend date
२०२६ मे २९
P/E ratio
२५.८१
52-wk high
US$ ३४१.८०
52-wk low
US$ २४४.५२
EPS
US$ १२.०९
Beta
०.८८
Shares outstanding
८.११ करोड
No. of employees
७१ हजार
News stories
From web sources and news partners
https://www.dars.gov.et/
https://www.dars.gov.et/
·
२ हप्ता पहिले
LH Q2 2026 Earnings: EPS Beat Overshadowed by 2.72% Share Decline - Book Value Growth
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees७१ हजार
Founded१९७८
HeadquartersBurlington, नर्थ क्यारोलाइना, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current US$ ३१२.१५
US$ ३८०.०० (+२१.७४%)
Average
US$ ३४३.५० (+१०.०४%)
Lowest
US$ ३०६.०० (-१.९७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Hold
Maintained
US$ ३३०.००
+५.७%
10/07/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
David S Macdonald
Truist Financial
Buy
Maintained
US$ ३६५.००
+१६.९%
09/21/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$ ३४०.००
+८.९%
09/11/2026
Kevin Caliendo
UBS
Buy
Maintained
US$ ३८०.००
+२१.७%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$ ३५५.००
+१३.७%
08/10/2026
David Westenberg
Piper Sandler
Hold
Reiterated
US$ ३०९.००
-१%
08/04/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
US$ ३०६.००
-२%
07/31/2026
Erin Wright
Morgan Stanley
Buy
Maintained
US$ ३३८.००
+८.३%
07/31/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
US$ ३५२.००
+१२.८%
07/31/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
US$ ३६०.००
+१५.३%
07/30/2026
David Toung
Argus Research
Buy
Maintained
US$ ३१०.००
-०.७%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
US$ ३२०.००
+२.५%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Last report
२०२६ जुलाई ३०
Fiscal period
Q2 2026
US$ ४.९९ / US$ ४.७७
+४.६५%beat
Revenue / Est. (USD)
३.७३ अरब / ३.७१ अरब
+०.४७%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३.५६ अरब
३.५२ अरब
३.५४ अरब
३.७३ अरब
Cost of goods sold
२.५४ अरब
२.५२ अरब
२.५२ अरब
२.६२ अरब
Cost of revenue
२.५४ अरब
२.५२ अरब
२.५२ अरब
२.६२ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.२४ करोड
५४.९७ करोड
५५.१० करोड
५७.७२ करोड
Operating expense
६२.१९ करोड
६२.२३ करोड
६२.६६ करोड
६५.५३ करोड
Total operating expenses
३.१६ अरब
३.१४ अरब
३.१५ अरब
३.२७ अरब
Operating income
४०.३२ करोड
३७.०९ करोड
३८.७२ करोड
४५.६७ करोड
Other non operating income
७.०० लाख
१९.०० लाख
-६.०० लाख
-३५.०० लाख
EBT including unusual items
३३.७० करोड
१९.०६ करोड
३१.९७ करोड
३८.६४ करोड
EBT excluding unusual items
३४.१३ करोड
३१.५२ करोड
३३.३२ करोड
३९.१५ करोड
Income tax expense
७.५५ करोड
२.५७ करोड
४.१७ करोड
८.७३ करोड
Effective tax rate
२२.४०%
१३.४८%
१३.०४%
२२.५९%
Other operating expenses
-
-
-
-
Net income
२६.११ करोड
१६.४७ करोड
२७.७८ करोड
२९.८७ करोड
Net profit margin
७.३३%
४.६८%
७.८५%
८.०१%
Earnings per share
४.१८
४.०७
४.२५
४.९९
Interest and investment income
३५.०० लाख
३५.०० लाख
१.२२ करोड
५६.०० लाख
Interest expense
-५.६० करोड
-५.५० करोड
-५.५१ करोड
-६.११ करोड
Net interest expenses
-५.२५ करोड
-५.१५ करोड
-४.२९ करोड
-५.५५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५७.४२ करोड
५४.९४ करोड
५६.०५ करोड
६३.५७ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू